Prevention of Necrotizing Enterocolitis Through Manipulation of the Intestinal Microbiota of the Premature Infant

Clinical Therapeutics

Volumn 38, Issue 4, 2016, Pages 716-732

  Vongbhavit, Kannikar ^a,b   Underwood, Mark A ^b  

^a SRINAKHARINWIROT UNIVERSITY   (Thailand)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Key words s: human milk; lactoferrin; necrotizing enterocolitis; prebiotic; premature infant probiotic; synbiotic

Indexed keywords

LACTOFERRIN; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT;

BACTERIAL COLONIZATION; BACTERIAL GENOME; BREAST MILK; DIETARY SUPPLEMENT; DISEASE ASSOCIATION; DYSBIOSIS; HUMAN; INTESTINE FLORA; LACTOBACILLUS; NECROTIZING ENTEROCOLITIS; OUTCOME ASSESSMENT; PREMATURITY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SACCHAROMYCES; TREATMENT RESPONSE; ENTEROCOLITIS, NECROTIZING; IMMUNOLOGY; INFANT; NEWBORN; PHYSIOLOGY;

DYSBIOSIS; ENTEROCOLITIS, NECROTIZING; GASTROINTESTINAL MICROBIOME; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE;

EID: 84957927263     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2016.01.006     Document Type: Review

References (166)

1. J. Neu, and W.A. Walker Necrotizing enterocolitis N Engl J Med 364 2011 255 264
2. K.M. Dominguez, and R.L. Moss Necrotizing enterocolitis Clin Perinatol 39 2012 387 401
3. S.J. McElroy, M.A. Underwood, and M.P. Sherman Paneth cells and necrotizing enterocolitis: a novel hypothesis for disease pathogenesis Neonatology 103 2013 10 20
4. M.J. Bell, J.L. Ternberg, R.D. Feigin, and et al. Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging Ann Surg 187 1978 1 7
5. M.C. Walsh, and R.M. Kliegman Necrotizing enterocolitis: treatment based on staging criteria Pediatr Clin North Am 33 1986 179 201
6. T.J. Johnson, A.L. Patel, H.R. Bigger, and et al. Cost savings of human milk as a strategy to reduce the incidence of necrotizing enterocolitis in very low birth weight infants Neonatology 107 2015 271 276
7. T.A. Shah, J. Meinzen-Derr, T. Gratton, and et al. Hospital and neurodevelopmental outcomes of extremely low-birth-weight infants with necrotizing enterocolitis and spontaneous intestinal perforation J Perinatol 32 2012 552 558
8. W.H. Yee, A.S. Soraisham, V.S. Shah, and et al. Incidence and timing of presentation of necrotizing enterocolitis in preterm infants Pediatrics 129 2012 e298 e304
9. N.H. Salzman, and C.L. Bevins Dysbiosis - a consequence of Paneth cell dysfunction Semin Immunol 25 2013 334 341
10. H.C. Clevers, and C.L. Bevins Paneth cells: maestros of the small intestinal crypts Annu Rev Physiol 75 2013 289 311
11. A.L. Morrow, A.J. Lagomarcino, K.R. Schibler, and et al. Early microbial and metabolomic signatures predict later onset of necrotizing enterocolitis in preterm infants Microbiome 1 2013 13
12. V. Mai, C.M. Young, M. Ukhanova, and et al. Fecal microbiota in premature infants prior to necrotizing enterocolitis PLoS One 6 2011 e20647
13. J.E. Berrington, C.J. Stewart, S.P. Cummings, and N.D. Embleton The neonatal bowel microbiome in health and infection Curr Opin Infect Dis 27 2014 236 243
14. N. Cassir, S. Benamar, J.B. Khalil, and et al. Clostridium butyricum Strains and dysbiosis linked to necrotizing enterocolitis in preterm neonates Clin Infect Dis 61 2015 1107 1115
15. S.E. Winter, and A.J. Baumler Dysbiosis in the inflamed intestine: chance favors the prepared microbe Gut Microbes 5 2014 71 73
16. A.N. Ardissone, D.M. de la Cruz, A.G. Davis-Richardson, and et al. Meconium microbiome analysis identifies bacteria correlated with premature birth PLoS One 9 2014 e90784
17. D.B. DiGiulio, M. Gervasi, R. Romero, and et al. Microbial invasion of the amniotic cavity in preeclampsia as assessed by cultivation and sequence-based methods J Perinat Med 38 2010 503 513
18. D.B. DiGiulio, M.T. Gervasi, R. Romero, and et al. Microbial invasion of the amniotic cavity in pregnancies with small-for-gestational-age fetuses J Perinat Med 38 2010 495 502
19. M.G. Dominguez-Bello, E.K. Costello, M. Contreras, and et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns Proc Natl Acad Sci U S A 107 2010 11971 11975
20. S. Arboleya, L. Ang, A. Margolles, and et al. Deep 16S rRNA metagenomics and quantitative PCR analyses of the premature infant fecal microbiota Anaerobe 18 2012 378 380
21. S. Arboleya, A. Binetti, N. Salazar, and et al. Establishment and development of intestinal microbiota in preterm neonates FEMS Microbiol Ecol 79 2012 763 772
22. C. Gomez-Llorente, J. Plaza-Diaz, M. Aguilera, and et al. Three main factors define changes in fecal microbiota associated with feeding modality in infants J Pediatr Gastroenterol Nutr 57 2013 461 466
23. J.E. Berrington, C.J. Stewart, N.D. Embleton, and S.P. Cummings Gut microbiota in preterm infants: assessment and relevance to health and disease Arch Dis Child Fetal Neonatal Ed 98 2013 F286 F290
24. H.E. Jakobsson, T.R. Abrahamsson, M.C. Jenmalm, and et al. Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section Gut 63 2014 559 566
25. C. Greenwood, A.L. Morrow, A.J. Lagomarcino, and et al. Early empiric antibiotic use in preterm infants is associated with lower bacterial diversity and higher relative abundance of Enterobacter J Pediatr 165 2014 23 29
26. P.S. La Rosa, B.B. Warner, Y. Zhou, and et al. Patterned progression of bacterial populations in the premature infant gut Proc Natl Acad Sci U S A 111 2014 12522 12527
27. R.W. Gupta, L. Tran, J. Norori, and et al. Histamine-2 receptor blockers alter the fecal microbiota in premature infants J Pediatr Gastroenterol Nutr 56 2013 397 400
28. R. Guillet, B.J. Stoll, C.M. Cotten, and et al. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants Pediatrics 117 2006 e137 e142
29. A.S. Weintraub, L. Ferrara, L. Deluca, and et al. Antenatal antibiotic exposure in preterm infants with necrotizing enterocolitis J Perinatol 32 2012 705 709
30. V.S. Kuppala, J. Meinzen-Derr, A.L. Morrow, and K.R. Schibler Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants J Pediatr 159 2011 720 725
31. B. Brooks, B.A. Firek, C.S. Miller, and et al. Microbes in the neonatal intensive care unit resemble those found in the gut of premature infants Microbiome 2 2014 1
32. Sohn K, Kalanetra K, Mills DA, et al. Buccal administration of human colostrum: impact on the oral microbiota. J Perinatol 2016;36:106-11.
33. P. Wacklin, J. Tuimala, J. Nikkila, and et al. Faecal microbiota composition in adults is associated with the FUT2 gene determining the secretor status PLoS One 9 2014 e94863
34. A.L. Morrow, J. Meinzen-Derr, P. Huang, and et al. Fucosyltransferase 2 non-secretor and low secretor status predicts severe outcomes in premature infants J Pediatr 158 2011 745 751
35. J. Meinzen-Derr, B. Poindexter, L. Wrage, and et al. Role of human milk in extremely low birth weight infants? risk of necrotizing enterocolitis or death J Perinatol 29 2009 57 62
36. M.A. Underwood Intestinal dysbiosis: novel mechanisms by which gut microbes trigger and prevent disease Prev Med 65 2014 133 137
37. K. AlFaleh, and J. Anabrees Probiotics for prevention of necrotizing enterocolitis in preterm infants Evid Based Child Health 9 2014 584 671
38. D.W. Thomas, and F.R. Greer Probiotics and prebiotics in pediatrics Pediatrics 126 2010 1217 1231
39. M.A. Underwood, J. Arriola, C.W. Gerber, and et al. Bifidobacterium longum subsp. infantis in experimental necrotizing enterocolitis: alterations in inflammation, innate immune response, and the microbiota Pediatr Res 76 2014 326 333
40. M.A. Underwood, A. Kananurak, C.F. Coursodon, and et al. Bifidobacterium bifidum in a rat model of necrotizing enterocolitis: antimicrobial peptide and protein responses Pediatr Res 71 2012 546 551
41. T. Satoh, H. Izumi, N. Iwabuchi, and et al. Bifidobacterium breve prevents necrotising enterocolitis by suppressing inflammatory responses in a preterm rat model Benef Microbes 2015 1 8
42. K. Ganguli, D. Meng, S. Rautava, and et al. Probiotics prevent necrotizing enterocolitis by modulating enterocyte genes that regulate innate immune-mediated inflammation Am J Physiol Gastrointest Liver Physiol 304 2013 G132 G141
43. M.A. Underwood, J.B. German, C.B. Lebrilla, and D.A. Mills Bifidobacterium longum subspecies infantis: champion colonizer of the infant gut Pediatr Res 77 2015 229 235
44. L. Khailova, K. Dvorak, K.M. Arganbright, and et al. Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis Am J Physiol Gastrointest Liver Physiol 297 2009 G940 G949
45. L. Khailova, S.K. Mount Patrick, K.M. Arganbright, and et al. Bifidobacterium bifidum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitis Am J Physiol Gastrointest Liver Physiol 299 2010 G1118 G1127
46. S. Arboleya, N. Salazar, G. Solis, and et al. Assessment of intestinal microbiota modulation ability of Bifidobacterium strains in in vitro fecal batch cultures from preterm neonates Anaerobe 19 2013 9 16
47. T. Fujii, Y. Ohtsuka, T. Lee, and et al. Bifidobacterium breve enhances transforming growth factor beta1 signaling by regulating Smad7 expression in preterm infants J Pediatr Gastroenterol Nutr 43 2006 83 88
48. F.L. Goncalves, L.M. Soares, R.L. Figueira, and et al. Evaluation of the expression of I-FABP and L-FABP in a necrotizing enterocolitis model after the use of Lactobacillus acidophilus J Pediatr Surg 50 2015 543 549
49. M. Good, C.P. Sodhi, J.A. Ozolek, and et al. Lactobacillus rhamnosus HN001 decreases the severity of necrotizing enterocolitis in neonatal mice and preterm piglets: evidence in mice for a role of TLR9 Am J Physiol Gastrointest Liver Physiol 306 2014 G1021 G1032
50. Y. Liu, N.Y. Fatheree, N. Mangalat, and J.M. Rhoads Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-kappaB signaling in the intestine Am J Physiol Gastrointest Liver Physiol 302 2012 G608 G617
51. A. Borthakur, S. Bhattacharyya, A. Kumar, and et al. Lactobacillus acidophilus alleviates platelet-activating factor-induced inflammatory responses in human intestinal epithelial cells PLoS One 8 2013 e75664
52. B. Biersmith, Z.H. Wang, and E.R. Geisbrecht Fine-tuning of the actin cytoskeleton and cell adhesion during Drosophila development by the unconventional guanine nucleotide exchange factors myoblast city and sponge Genetics 200 2015 551 567
53. Y. Liu, N.Y. Fatheree, B.M. Dingle, and et al. Lactobacillus reuteri DSM 17938 changes the frequency of Foxp3+ regulatory T cells in the intestine and mesenteric lymph node in experimental necrotizing enterocolitis PLoS One 8 2013 e56547
54. W.A. Kunze, Y.K. Mao, B. Wang, and et al. Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium-dependent potassium channel opening J Cell Mol Med 13 2009 2261 2270
55. J. Mirpuri, I. Sotnikov, L. Myers, and et al. Lactobacillus rhamnosus (LGG) regulates IL-10 signaling in the developing murine colon through upregulation of the IL-10R2 receptor subunit PLoS One 7 2012 e51955
56. P.W. Lin, T.R. Nasr, A.J. Berardinelli, and et al. The probiotic Lactobacillus GG may augment intestinal host defense by regulating apoptosis and promoting cytoprotective responses in the developing murine gut Pediatr Res 64 2008 511 516
57. R.M. Patel, L.S. Myers, A.R. Kurundkar, and et al. Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function Am J Pathol 180 2012 626 635
58. F. Yan, and D.B. Polk Characterization of a probiotic-derived soluble protein which reveals a mechanism of preventive and treatment effects of probiotics on intestinal inflammatory diseases Gut Microbes 3 2012 25 28
59. R. Olsen, G. Greisen, M. Schroder, and J. Brok Prophylactic probiotics for preterm infants: a systematic review and meta-analysis of observational studies Neonatology 109 2015 105 112
60. K. Costeloe, P. Hardy, E. Juszczak, and et al. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial Lancet 2015 http://dx.doi.org/10.1016/S0140-6736(15)01027-2. [Epub ahead of print]
61. D. Dilli, B. Aydin, N.D. Fettah, and et al. The propre-save study: effects of probiotics and prebiotics alone or combined on necrotizing enterocolitis in very low birth weight infants J Pediatr 166 2015 545-51e1
62. V. Saengtawesin, R. Tangpolkaiwalsak, and W. Kanjanapattankul Effect of oral probiotics supplementation in the prevention of necrotizing enterocolitis among very low birth weight preterm infants J Med Assoc Thai 97 Suppl 6 2014 S20 S25
63. V.V. Tewari, S.K. Dubey, and G. Gupta Bacillus clausii for prevention of late-onset sepsis in preterm infants: a randomized controlled trial J Trop Pediatr 61 2015 377 385
64. S. Hays, A. Jacquot, H. Gauthier, and et al. Probiotics and growth in preterm infants: a randomized controlled trial, PREMAPRO study Clin Nutr 2015 http://dx.doi.org/10.1016/j.clnu.2015.06.006. [Epub ahead of print]
65. E. Van Niekerk, D.G. Nel, R. Blaauw, and G.F. Kirsten Probiotics reduce necrotizing enterocolitis severity in HIV-exposed premature infants J Trop Pediatr 61 2015 155 164
66. S. Dutta, P. Ray, and A. Narang Comparison of stool colonization in premature infants by three dose regimes of a probiotic combination: a randomized controlled trial Am J Perinatol 32 2015 733 740
67. S. Patole, A.D. Keil, A. Chang, and et al. Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates - a randomised double blind placebo controlled trial PLoS One 9 2014 e89511
68. M.Y. Oncel, F.N. Sari, S. Arayici, and et al. Lactobacillus reuteri for the prevention of necrotising enterocolitis in very low birthweight infants: a randomised controlled trial Arch Dis Child Fetal Neonatal Ed 99 2014 F110 F115
69. S. Totsu, C. Yamasaki, M. Terahara, and et al. Bifidobacterium and enteral feeding in preterm infants: cluster-randomized trial Pediatr Int 56 2014 714 719
70. S.E. Jacobs, J.M. Tobin, G.F. Opie, and et al. Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial Pediatrics 132 2013 1055 1062
71. O. Serce, D. Benzer, T. Gursoy, and et al. Efficacy of Saccharomyces boulardii on necrotizing enterocolitis or sepsis in very low birth weight infants: a randomised controlled trial Early Hum Dev 89 2013 1033 1036
72. G. Demirel, O. Erdeve, I.H. Celik, and U. Dilmen Saccharomyces boulardii for prevention of necrotizing enterocolitis in preterm infants: a randomized, controlled study Acta Paediatr 102 2013 e560 e565
73. M.A. Rojas, J.M. Lozano, M.X. Rojas, and et al. Prophylactic probiotics to prevent death and nosocomial infection in preterm infants Pediatrics 130 2012 e1113 e1120
74. L.A. Fernandez-Carrocera, A. Solis-Herrera, M. Cabanillas-Ayon, and et al. Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis Arch Dis Child Fetal Neonatal Ed 98 2013 F5 F9
75. M. Al-Hosni, M. Duenas, M. Hawk, and et al. Probiotics-supplemented feeding in extremely low-birth-weight infants J Perinatol 32 2012 253 259
76. F.N. Sari, E.A. Dizdar, S. Oguz, and et al. Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial Eur J Clin Nutr 65 2011 434 439
77. T.D. Braga, G.A. da Silva, P.I. de Lira, and M. de Carvalho Lima Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial Am J Clin Nutr 93 2011 81 86
78. M.G. Romeo, D.M. Romeo, L. Trovato, and et al. Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome J Perinatol 31 2011 63 69
79. H. Awad, H. Mokhtar, S.S. Imam, and et al. Comparison between killed and living probiotic usage versus placebo for the prevention of necrotizing enterocolitis and sepsis in neonates Pak J Biol Sci 13 2010 253 262
80. W.A. Mihatsch, S. Vossbeck, B. Eikmanns, and et al. Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: a randomized controlled trial Neonatology 98 2010 156 163
81. M. Samanta, M. Sarkar, P. Ghosh, and et al. Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns J Trop Pediatr 55 2009 128 131
82. C. Rouge, H. Piloquet, M.J. Butel, and et al. Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial Am J Clin Nutr 89 2009 1828 1835
83. H.C. Lin, C.H. Hsu, H.L. Chen, and et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial Pediatrics 122 2008 693 700
84. Z. Stratiki, C. Costalos, S. Sevastiadou, and et al. The effect of a bifidobacter supplemented bovine milk on intestinal permeability of preterm infants Early Hum Dev 83 2007 575 579
85. C. Wang, H. Shoji, H. Sato, and et al. Effects of oral administration of Bifidobacterium breve on fecal lactic acid and short-chain fatty acids in low birth weight infants J Pediatr Gastroenterol Nutr 44 2007 252 257
86. P. Manzoni, M. Mostert, M.L. Leonessa, and et al. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study Clin Infect Dis 42 2006 1735 1742
87. H.C. Lin, B.H. Su, A.C. Chen, and et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants Pediatrics 115 2005 1 4
88. A. Bin-Nun, R. Bromiker, M. Wilschanski, and et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates J Pediatr 147 2005 192 196
89. C. Costalos, V. Skouteri, A. Gounaris, and et al. Enteral feeding of premature infants with Saccharomyces boulardii Early Hum Dev 74 2003 89 96
90. C. Dani, R. Biadaioli, G. Bertini, and et al. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants: a prospective double-blind study Biol Neonate 82 2002 103 108
91. P.D. Reuman, D.H. Duckworth, K.L. Smith, and et al. Lack of effect of Lactobacillus on gastrointestinal bacterial colonization in premature infants Pediatr Infect Dis 5 1986 663 668
92. S. Dang, L. Shook, K. Garlitz, and et al. Nutritional outcomes with implementation of probiotics in preterm infants J Perinatol 35 2015 447 450
93. A. Repa, M. Thanhaeuser, D. Endress, and et al. Probiotics (Lactobacillus acidophilus and Bifidobacterium bifidum) prevent NEC in VLBW infants fed breast milk but not formula Pediatr Res 77 2015 381 388
94. C. Hartel, J. Pagel, J. Rupp, and et al. Prophylactic use of Lactobacillus acidophilus/Bifidobacterium infantis probiotics and outcome in very low birth weight infants J Pediatr 165 2014 285-9e1
95. A. Janvier, J. Malo, and K.J. Barrington Cohort study of probiotics in a North American neonatal intensive care unit J Pediatr 164 2014 980 985
96. F. Bonsante, S. Iacobelli, and J.B. Gouyon Routine probiotic use in very preterm infants: retrospective comparison of two cohorts Am J Perinatol 30 2013 41 46
97. D. Li, G. Rosito, and T. Slagle Probiotics for the prevention of necrotizing enterocolitis in neonates: an 8-year retrospective cohort study J Clin Pharm Ther 38 2013 445 449
98. C. Hunter, M.A. Dimaguila, P. Gal, and et al. Effect of routine probiotic, Lactobacillus reuteri DSM 17938, use on rates of necrotizing enterocolitis in neonates with birthweight <1000 grams: a sequential analysis BMC Pediatr 12 2012 142
99. R. Luoto, J. Matomaki, E. Isolauri, and L. Lehtonen Incidence of necrotizing enterocolitis in very-low-birth-weight infants related to the use of Lactobacillus GG Acta Paediatr 99 2010 1135 1138
100. Y. Yamashiro, and S. Nagata Beneficial microbes for premature infants, and children with malignancy undergoing chemotherapy Benef Microbes 1 2010 357 365
101. A.B. Hoyos Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit Int J Infect Dis 3 1999 197 202
102. Lewis ZT, Shani G, Masarweh C, et al. Validating bifidobacterial species and subspecies identity in commercial probiotic products. Pediatr Res 2015. http//dx.doi.org/10.1038/pr.2015.244. [Epub ahead of print]
103. A. Marcobal, M.A. Underwood, and D.A. Mills Rapid determination of the bacterial composition of commercial probiotic products by terminal restriction fragment length polymorphism analysis J Pediatr Gastroenterol Nutr 46 2008 608 611
104. L. Hickey, S.M. Garland, S.E. Jacobs, and et al. Cross-colonization of infants with probiotic organisms in a neonatal unit J Hosp Infect 88 2014 226 229
105. M.A. Underwood, K.M. Kalanetra, N.A. Bokulich, and et al. A comparison of two probiotic strains of bifidobacteria in premature infants J Pediatr 163 2013 1585-91e9
106. S. Vallabhaneni, T.A. Walker, S.R. Lockhart, and et al. Notes from the field: fatal gastrointestinal mucormycosis in a premature infant associated with a contaminated dietary supplement - Connecticut, 2014 MMWR Morb Mortal Wkly Rep 64 2015 155 156
107. C. Bertelli, T. Pillonel, A. Torregrossa, and et al. Bifidobacterium longum bacteremia in preterm infants receiving probiotics Clin Infect Dis 60 2015 924 927
108. A. Ohishi, S. Takahashi, Y. Ito, and et al. Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele J Pediatr 156 2010 679 681
109. C. Thompson, Y.S. McCarter, P.J. Krause, and V.C. Herson Lactobacillus acidophilus sepsis in a neonate J Perinatol 21 2001 258 260
110. P. Panigrahi Probiotics and prebiotics in neonatal necrotizing enterocolitis: new opportunities for translational research Pathophysiology 21 2014 35 46
111. R.W. Hutkins, J.A. Krumbeck, L.B. Bindels, and et al. Prebiotics: why definitions matter Curr Opin Biotechnol 37 2015 1 7
112. K.S. Peacock, L.R. Ruhaak, M.K. Tsui, and et al. Isomer-specific consumption of galactooligosaccharides by bifidobacterial species J Agric Food Chem 61 2013 12612 12619
113. H. Makelainen, M. Saarinen, J. Stowell, and et al. Xylo-oligosaccharides and lactitol promote the growth of Bifidobacterium lactis and Lactobacillus species in pure cultures Benef Microbes 1 2010 139 148
114. R. Srinivasjois, S. Rao, and S. Patole Prebiotic supplementation in preterm neonates: updated systematic review and meta-analysis of randomised controlled trials Clin Nutr 32 2013 958 965
115. E.A. Westerbeek, R.A. Slump, H.N. Lafeber, and et al. The effect of enteral supplementation of specific neutral and acidic oligosaccharides on the faecal microbiota and intestinal microenvironment in preterm infants Eur J Clin Microbiol Infect Dis 32 2013 269 276
116. E. Barrett, A.K. Deshpandey, C.A. Ryan, and et al. The neonatal gut harbours distinct bifidobacterial strains Arch Dis Child Fetal Neonatal Ed 100 2015 F405 F410
117. F. Indrio, G. Riezzo, F. Raimondi, and et al. Prebiotics improve gastric motility and gastric electrical activity in preterm newborns J Pediatr Gastroenterol Nutr 49 2009 258 261
118. E.A. Westerbeek, R.L. Hensgens, W.A. Mihatsch, and et al. The effect of neutral and acidic oligosaccharides on stool viscosity, stool frequency and stool pH in preterm infants Acta Paediatr 100 2011 1426 1431
119. M. Roberfroid, G.R. Gibson, L. Hoyles, and et al. Prebiotic effects: metabolic and health benefits Br J Nutr 104 Suppl 2 2010 S1 63
120. S. Fukuda, H. Toh, K. Hase, and et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate Nature 469 2011 543 547
121. S. Seifert, and B. Watzl Inulin and oligofructose: review of experimental data on immune modulation J Nutr 137 2007 2563S 2567SS
122. Y. Vandenplas, I. Zakharova, and Y. Dmitrieva Oligosaccharides in infant formula: more evidence to validate the role of prebiotics Br J Nutr 113 2015 1339 1344
123. H.D. Holscher, K.L. Faust, L.A. Czerkies, and et al. Effects of prebiotic-containing infant formula on gastrointestinal tolerance and fecal microbiota in a randomized controlled trial JPEN J Parenter Enteral Nutr 36 2012 95S 105S
124. A.M. Armanian, A. Sadeghnia, M. Hoseinzadeh, and et al. The effect of neutral oligosaccharides on reducing the incidence of necrotizing enterocolitis in preterm infants: a randomized clinical trial Int J Prev Med 5 2014 1387 1395
125. A. Riskin, O. Hochwald, D. Bader, and et al. The effects of lactulose supplementation to enteral feedings in premature infants: a pilot study J Pediatr 156 2010 209 214
126. N. Modi, S. Uthaya, J. Fell, and E. Kulinskaya A randomized, double-blind, controlled trial of the effect of prebiotic oligosaccharides on enteral tolerance in preterm infants (ISRCTN77444690) Pediatr Res 68 2010 440 445
127. E.A. Westerbeek, J.P. van den Berg, H.N. Lafeber, and et al. Neutral and acidic oligosaccharides in preterm infants: a randomized, double-blind, placebo-controlled trial Am J Clin Nutr 91 2010 679 686
128. N. Niele, A. van Zwol, E.A. Westerbeek, and et al. Effect of non-human neutral and acidic oligosaccharides on allergic and infectious diseases in preterm infants Eur J Pediatr 172 2013 317 323
129. J.P. van den Berg, E.A. Westerbeek, F.R. van der Klis, and et al. Neutral and acidic oligosaccharides supplementation does not increase the vaccine antibody response in preterm infants in a randomized clinical trial PLoS One 8 2013 e70904
130. L.P. Nandhini, N. Biswal, B. Adhisivam, and et al. Synbiotics for decreasing incidence of necrotizing enterocolitis among preterm neonates - a randomized controlled trial J Matern Fetal Neonatal Med 2015 1 5
131. M.A. Underwood, N.H. Salzman, S.H. Bennett, and et al. A randomized placebo-controlled comparison of 2 prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids J Pediatr Gastroenterol Nutr 48 2009 216 225
132. H. Tian, I.S. Maddox, L.R. Ferguson, and Q. Shu Influence of bovine lactoferrin on selected probiotic bacteria and intestinal pathogens Biometals 23 2010 593 596
133. B. Lonnerdal, and S. Iyer Lactoferrin: molecular structure and biological function Annu Rev Nutr 15 1995 93 110
134. M.P. Sherman, M.M. Miller, J. Sherman, and V. Niklas Lactoferrin and necrotizing enterocolitis Curr Opin Pediatr 26 2014 146 150
135. V.I. Holden, and M.A. Bachman Diverging roles of bacterial siderophores during infection Metallomics 7 2015 986 995
136. G. Kaur, and G. Gathwala Efficacy of bovine lactoferrin supplementation in preventing late-onset sepsis in low birth weight neonates: a randomized placebo-controlled clinical trial J Trop Pediatr 61 2015 370 376
137. T.J. Ochoa, J. Zegarra, L. Cam, and et al. Randomized controlled trial of lactoferrin for prevention of sepsis in peruvian neonates less than 2500 g Pediatr Infect Dis J 34 2015 571 576
138. I.M. Akin, B. Atasay, F. Dogu, and et al. Oral lactoferrin to prevent nosocomial sepsis and necrotizing enterocolitis of premature neonates and effect on T-regulatory cells Am J Perinatol 31 2014 1111 1120
139. P. Manzoni, M. Meyer, I. Stolfi, and et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial Early Hum Dev 90 Suppl 1 2014 S60 S65
140. M.P. Sherman, V. Niklas, P. Radmacher, and et al. A clinical trial of talactoferrin to reduce infection in very preterm infants: safety and efficacy 2013 Pediatric Academic Societies Washington, D.C
141. M. Pammi, and S.A. Abrams Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants Cochrane Database Syst Rev 2015 2 CD007137
142. C.G. Turin, A. Zea-Vera, A. Pezo, and et al. Lactoferrin for prevention of neonatal sepsis Biometals 27 2014 1007 1016
143. J.T. Smilowitz, C.B. Lebrilla, D.A. Mills, and et al. Breast milk oligosaccharides: structure-function relationships in the neonate Annu Rev Nutr 34 2014 143 169
144. S. Ruiz-Moyano, S.M. Totten, D.A. Garrido, and et al. Variation in consumption of human milk oligosaccharides by infant gut-associated strains of Bifidobacterium breve Appl Environ Microbiol 79 2013 6040 6049
145. D. Garrido, D.C. Dallas, and D.A. Mills Consumption of human milk glycoconjugates by infant-associated bifidobacteria: mechanisms and implications Microbiology 159 2013 649 664
146. J.H. Kim, H.J. An, D Garrido, and et al. Proteomic analysis of Bifidobacterium longum subsp. infantis reveals the metabolic insight on consumption of prebiotics and host glycans PLoS One 8 2013 e57535
147. D.A. Sela, D. Garrido, L. Lerno, and et al. Bifidobacterium longum subsp. infantis ATCC 15697 alpha-fucosidases are active on fucosylated human milk oligosaccharides Appl Environ Microbiol 78 2012 795 803
148. R.G. LoCascio, P. Desai, D.A. Sela, and et al. Broad conservation of milk utilization genes in Bifidobacterium longum subsp. infantis as revealed by comparative genomic hybridization Appl Environ Microbiol 76 2010 7373 7381
149. M.A. Underwood Human milk for the premature infant Pediatr Clin North Am 60 2013 189 207
150. Underwood MA, Gaerlan S, De Leoz ML, et al. Human milk oligosaccharides in premature infants: absorption, excretion, and influence on the intestinal microbiota. Pediatr Res 2015.
151. D. Garrido, S. Ruiz-Moyano, D.G. Lemay, and et al. Comparative transcriptomics reveals key differences in the response to milk oligosaccharides of infant gut-associated bifidobacteria Sci Rep 5 2015 13517
152. L.R. Ruhaak, C. Stroble, M.A. Underwood, and C.B. Lebrilla Detection of milk oligosaccharides in plasma of infants Anal Bioanal Chem 406 2014 5775 5784
153. M.L. De Leoz, S. Wu, J.S. Strum, and et al. A quantitative and comprehensive method to analyze human milk oligosaccharide structures in the urine and feces of infants Anal Bioanal Chem 405 2013 4089 4105
154. M.L. De Leoz, S.C. Gaerlan, J.S. Strum, and et al. Lacto-N-tetraose, fucosylation, and secretor status are highly variable in human milk oligosaccharides from women delivering preterm J Proteome Res 11 2012 4662 4672
155. M. Tong, I. McHardy, P. Ruegger, and et al. Reprograming of gut microbiome energy metabolism by the FUT2 Crohn?s disease risk polymorphism ISME J 8 2014 2193 2206
156. A.S. Parmar, N. Alakulppi, P. Paavola-Sakki, and et al. Association study of FUT2 (rs601338) with celiac disease and inflammatory bowel disease in the Finnish population Tissue Antigens 80 2012 488 493
157. D.C. Payne, R.L. Currier, M.A. Staat, and et al. Epidemiologic association between FUT2 secretor status and severe rotavirus gastroenteritis in children in the United States JAMA Pediatr 169 2015 1040 1045
158. R.L. Currier, D.C. Payne, M.A. Staat, and et al. Innate Susceptibility to norovirus infections influenced by FUT2 genotype in a United States pediatric population Clin Infect Dis 60 2015 1631 1638
159. Z.T. Lewis, S.M. Totten, J.T. Smilowitz, and et al. Maternal fucosyltransferase 2 status affects the gut bifidobacterial communities of breastfed infants Microbiome 3 2015 13
160. E. Jantscher-Krenn, M. Zherebtsov, C. Nissan, and et al. The human milk oligosaccharide disialyllacto-N-tetraose prevents necrotising enterocolitis in neonatal rats Gut 61 2012 1417 1425
161. H. Yu, K. Lau, V. Thon, and et al. Synthetic disialyl hexasaccharides protect neonatal rats from necrotizing enterocolitis Angew Chem Int Ed Engl 53 2014 6687 6691
162. E. Van Niekerk, C.A. Autran, D.G. Nel, and et al. Human milk oligosaccharides differ between HIV-infected and HIV-uninfected mothers and are related to necrotizing enterocolitis incidence in their preterm very-low-birth-weight infants J Nutr 144 2014 1227 1233
163. P.V. Jeurink, J. van Bergenhenegouwen, E. Jimenez, and et al. Human milk: a source of more life than we imagine Benef Microbes 4 2013 17 30
164. S. Rautava, E. Kainonen, S. Salminen, and E. Isolauri Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant J Allergy Clin Immunol 130 2012 1355 1360
165. S. Benor, R. Marom, A. Ben Tov, and et al. Probiotic supplementation in mothers of very low birth weight infants Am J Perinatol 31 2014 497 504
166. J.A. Jacob Another frontier in microbiome research: preterm birth JAMA 314 2015 1550 1551